Phosphodiesterase type 5 inhibitors and erectile dysfunction
Erectile dysfunction (ED) affects millions of men globally and may adversely affect his, and potentially his partners’, quality of life. The introduction, a decade ago, of the phosphodiesterase type 5- (PDE5-) inhibitors has revolutionised the management of ED. The PDE5-inhibitors have provided an e...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AOSIS
2010-06-01
|
| Serie: | South African Family Practice |
| Soggetti: | |
| Accesso online: | https://safpj.co.za/index.php/safpj/article/view/1581 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|